Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign "TRAIGE"

Recruiting

Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to determine if computed tomography angiography can predict which individuals with intracerebral hemorrhage will experience significant growth in the size of the hemorrhage. For individuals who are at high risk for hemorrhage growth, the study will compare the drug Tranexamic acid to placebo to determine the effect and safety of on intracerebral hemorrhage growth

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 September 2016.

1 Sep 2015 7 Dec 2015 1 Dec 2018 Unavailable 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Liping Liu, MD

    8610-67098368